Suzhou KP Chemical Assists In The Development Of COVID-19 Drug-- Synthesis Of Remdesivir Intermediate

Suzhou KP Chemical Assists In The Development Of COVID-19 Drug-- Synthesis Of Remdesivir Intermediate

The FDA issued an emergency authorization for Gilead Scientific ’s antiviral drug Remdesivir, allowing the drug to be used for the treatment of suspected and diagnosed children and adults with COVID-19 in severely ill hospitals. 5 and 10 days of treatment time will be allowed. .

Nature( 2016, 531(7594), 381-385 ) reports on the synthesis method of Remdesivir, see the picture below.

In patent WO2016069825, in the example of compound 1 and compound 2 used to prepare compound 3, rare earth compound anhydrous lanthanum chloride (LaCl₃), anhydrous cerium chloride (CeCl₃), anhydrous yttrium chloride (YCl₃) and anhydrous neodymium chloride (NdCl₃) are used.

Anhydrous rare earth chloride is the superior product of Suzhou KP Chemical Co., Ltd. We can provide these four products. Please contact info@KPchemical.com or 086-18915544907.